NP90425 Faricimab (Vabysmo®)
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- not specified
- Value
- £48M
- Sector
- HEALTH
- Published
- 11 Feb 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
Edinburgh
Geochart for 2 buyers and 1 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Roche Products Welwyn Garden City
Description
Supply of Faricimab (Vabysmo®) to NHSScotland.
Total Quantity or Scope
The Framework Agreement is for the supply of Faricimab (Vabysmo®) to NHSScotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Award Detail
| 1 | Roche Products (Welwyn Garden City)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.
Other Information
The estimated value of the Framework Agreement referred to in Section V.2.4 covers the nine (9) month contract duration and the three (3) x twelve (12) month extension periods of the Framework Agreement. (SC Ref:821053)
Reference
- FTS 012346-2026